Back to Results
First PageMeta Content
Financial markets / Securities / United States securities law / Financial analyst / Securities research / Investment banking / Needham & Company / Financial Industry Regulatory Authority / Short / Finance / Financial economics / Business


Document Date: 2013-12-03 09:36:33

Open Document

File Size: 278,64 KB

Share Result on Facebook

Company

Pluristem Therapeutics Inc. / United Therapeutics / Needham / Biotechnology & Life Sciences Pluristem Therapeutics Inc. / Needham & Company LLC / Options Clearing Corporation / /

Country

United States / /

Currency

USD / /

/

Event

FDA Phase / Business Partnership / /

IndustryTerm

biopharmaceutical / grade product / banking / 3D cell culture technology / manufacturing capabilities / /

MedicalCondition

intermittent claudication / muscle injury / burn / degenerative diseases / Buerger's disease / Buerger’s disease / Pulmonary Hypertension / inflammatory / /

MedicalTreatment

stem cell therapy / cell therapy / /

OperatingSystem

PluriX / /

Organization

FDA / European Union / FINRA / /

Person

Bryan Huang / Mark Monane / /

/

Position

author / advisor / board member / officer / director / sales representative / analyst / analyst and research associate / sales representative for specific guidance / research associate / Jun ANALYST / /

Product

4Q11 / PLX-PAD / /

ProvinceOrState

New York / /

Technology

3D cell culture technology / cell therapy / regenerative medicine / /

URL

http /

SocialTag